About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.
2BB score and signals
Intuitive Surgical, Inc.’s current 2BB score is 60 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 57 | Moderate |
| Momentum | 52 | Stable |
| Financial strength | 92 | Very Strong |
| Quality | 100 | Very Strong |
| Risk | 32 | Low |
Company facts
| CEO | David J. Rosa |
| Headquarters | Sunnyvale, California, United States |
| Founded | 1995 |
| Employees | 17K |
| P/E ratio | 42.07 |
| 52-week range | $328.57 – $603.88 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-01-20 | — | 2.9012 | — | $3.28B |
| 2026-10-19 | — | 2.6891 | — | $2.96B |
| 2026-07-16 | 2.8 | 2.5503 | $2.89B | $2.88B |
| 2026-04-21 | 2.5 | 2.1409 | $2.77B | $2.67B |
Related companies
